User menu

Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial

Bibliographic reference Clement, P M ; Gauler, T ; Machiels, Jean-Pascal ; Haddad, R I ; Fayette, J ; et. al. Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial. In: Annals of Oncology, Vol. 27, no.8, p. 1585-1593 (2016)
Permanent URL http://hdl.handle.net/2078.1/182662